Issue navigation
Volume 63, Issue 5, May 2009
Reviews
Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 849–861, https://doi.org/10.1093/jac/dkp065
Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 862–867, https://doi.org/10.1093/jac/dkp083
ORIGINAL RESEARCH
Spread without known selective pressure of a vancomycin-resistant clone of Enterococcus faecium among broilers
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 868–872, https://doi.org/10.1093/jac/dkp045
Genotypic and phenotypic relationships among methicillin-resistant Staphylococcus aureus from three multicentre bacteraemia studies
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 873–876, https://doi.org/10.1093/jac/dkp047
StaphVar-DNA microarray analysis of accessory genome elements of community-acquired methicillin-resistant Staphylococcus aureus
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 877–885, https://doi.org/10.1093/jac/dkp089
Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 886–894, https://doi.org/10.1093/jac/dkp057
Novel CTX-M β-lactamase genotype distribution and spread into multiple species of Enterobacteriaceae in Changsha, Southern China
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 895–900, https://doi.org/10.1093/jac/dkp068
Identification of blaIMP-22 in Pseudomonas spp. in urban wastewater and nosocomial environments: biochemical characterization of a new IMP metallo-enzyme variant and its genetic location
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 901–908, https://doi.org/10.1093/jac/dkp061
Ciprofloxacin selects for multidrug resistance in Salmonella enterica serovar Typhimurium mediated by at least two different pathways
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 909–916, https://doi.org/10.1093/jac/dkp054
Characterization of fluoroquinolone-resistant Shigella flexneri in Hangzhou area of China
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 917–920, https://doi.org/10.1093/jac/dkp087
Evidence that impurities contribute to the fluorescence of the polyene antibiotic amphotericin B
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 921–927, https://doi.org/10.1093/jac/dkp059
Inhibition of MptpB phosphatase from Mycobacterium tuberculosis impairs mycobacterial survival in macrophages
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 928–936, https://doi.org/10.1093/jac/dkp031
Effect of a solution containing citrate/Methylene Blue/parabens on Staphylococcus aureus bacteria and biofilm, and comparison with various heparin solutions
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 937–945, https://doi.org/10.1093/jac/dkp060
Sensitization of Campylobacter jejuni to fluoroquinolone and macrolide antibiotics by antisense inhibition of the CmeABC multidrug efflux transporter
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 946–948, https://doi.org/10.1093/jac/dkp067
Vinaxanthone, a new FabI inhibitor from Penicillium sp.
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 949–953, https://doi.org/10.1093/jac/dkp058
Spectrum of activity and mode of action of REP3123, a new antibiotic to treat Clostridium difficile infections
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 954–963, https://doi.org/10.1093/jac/dkp041
Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection model
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 964–971, https://doi.org/10.1093/jac/dkp042
Comparative in vitro activity of REP3123 against Clostridium difficile and other anaerobic intestinal bacteria
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 972–976, https://doi.org/10.1093/jac/dkp037
Daptomycin pharmacodynamics against Staphylococcus aureus hemB mutants displaying the small colony variant phenotype
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 977–981, https://doi.org/10.1093/jac/dkp069
Pharmacodynamic evaluation of tigecycline against Acinetobacter baumannii in a murine pneumonia model
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 982–987, https://doi.org/10.1093/jac/dkp056
Nevirapine pharmacokinetics in HIV-infected and HIV/HCV-coinfected individuals
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 988–991, https://doi.org/10.1093/jac/dkp044
Saquinavir exposure in HIV-infected patients with chronic viral hepatitis
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 992–997, https://doi.org/10.1093/jac/dkp070
Peripheral and visceral fat changes following a treatment switch to a non-thymidine analogue or a nucleoside-sparing regimen in HIV-infected subjects with peripheral lipoatrophy: results of ACTG A5110
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 998–1005, https://doi.org/10.1093/jac/dkp071
Design and validation of new genotypic tools for easy and reliable estimation of HIV tropism before using CCR5 antagonists
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 1006–1010, https://doi.org/10.1093/jac/dkp063
Effect of long-term trimethoprim/sulfamethoxazole treatment on resistance and integron prevalence in the intestinal flora: a randomized, double-blind, placebo-controlled trial in children
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 1011–1016, https://doi.org/10.1093/jac/dkp050
Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 1017–1024, https://doi.org/10.1093/jac/dkp034
Impact of intravenous β-lactam/macrolide versus β-lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 1025–1033, https://doi.org/10.1093/jac/dkp088
Community-based outpatient parenteral antimicrobial therapy (CoPAT) for Staphylococcus aureus bacteraemia with or without infective endocarditis: analysis of the randomized trial comparing daptomycin with standard therapy
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 1034–1042, https://doi.org/10.1093/jac/dkp051
Eight years' experience of an extended-interval dosing protocol for gentamicin in neonates
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 1043–1049, https://doi.org/10.1093/jac/dkp073
Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 1050–1057, https://doi.org/10.1093/jac/dkp085
Impact of a computer-generated alert system prompting review of antibiotic use in hospitals
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 1058–1063, https://doi.org/10.1093/jac/dkp062
Quantifying changes in incidences of nosocomial bacteraemia caused by antibiotic-susceptible and antibiotic-resistant pathogens
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 1064–1070, https://doi.org/10.1093/jac/dkp036
Research Letters
Diversity of plasmid-mediated carbapenem-hydrolysing oxacillinases among carbapenem-resistant Acinetobacter baumannii isolates from Kingdom of Bahrain
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 1071–1073, https://doi.org/10.1093/jac/dkp052
Emergence of extended-spectrum-AmpC-expressing Escherichia coli isolates in Belgian hospitals
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 1073–1075, https://doi.org/10.1093/jac/dkp046
Reduced susceptibility of multidrug-resistant Acinetobacter baumannii to tigecycline in combination with 1-(1-naphthylmethyl)-piperazine is not a pH-dependent phenomenon
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 1075–1076, https://doi.org/10.1093/jac/dkp072
In vitro effect of metronidazole and vancomycin in combination on Clostridium difficile
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Page 1076, https://doi.org/10.1093/jac/dkp048
Detecting streptomycin in apples from orchards treated for fire blight
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 1076–1077, https://doi.org/10.1093/jac/dkp055
Letters to the Editor
Comment on: Resistance of planktonic and biofilm-grown Burkholderia cepacia complex isolates to the transition metal gallium
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 1078–1079, https://doi.org/10.1093/jac/dkp086
Resistance of planktonic and biofilm-grown Burkholderia cepacia complex isolates to the transition metal gallium—authors’ response
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Page 1079, https://doi.org/10.1093/jac/dkp110
Comment on: High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Page 1080, https://doi.org/10.1093/jac/dkn556
High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients—authors' response
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 1080–1081, https://doi.org/10.1093/jac/dkp064
Comment on: Aminoglycoside drugs in clinical practice: an evidence-based approach
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 1081–1082, https://doi.org/10.1093/jac/dkp053
Aminoglycoside drugs in clinical practice: an evidence-based approach—authors' response
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 1082–1083, https://doi.org/10.1093/jac/dkp091
Comment on: The higher the number of daily doses of antibiotic treatment in lower respiratory tract infection the worse the compliance
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 1083–1084, https://doi.org/10.1093/jac/dkp049
The higher the number of daily doses of antibiotic treatment in lower respiratory tract infection the worse the compliance—author's response
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Pages 1084–1085, https://doi.org/10.1093/jac/dkp093
Book Review
Antimicrobial Drugs: Chronicle of a Twentieth Century Medical Triumph
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 5, May 2009, Page 1086, https://doi.org/10.1093/jac/dkp066
